Clinical Predictive Factors of Response to Biologics in IBD
Background: Growing insights into complex molecular pathways involved in the pathogenesis of inflammatory bowel diseases (IBD) have led to advent of new treatment options. Currently, there are three classes of biological agents approved for the treatment of IBD: anti-tumor necrosis factor agents (an...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bucharest College of Physicians
2022-03-01
|
| Series: | Modern Medicine |
| Subjects: | |
| Online Access: | https://medicinamoderna.ro/wp-content/uploads/2022/03/Clinical-Predictive-Factors-of-Response-to-Biologics-in-IBD.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|